SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001021231-03-000405
Filing Date
2003-03-28
Accepted
2003-03-28 10:56:29
Documents
15
Period of Report
2003-03-28

Document Format Files

Seq Description Document Type Size
1 b701404-20f.htm 20-F 3992813
3 GRAPHIC b701404-20f_01x3x1.jpg GRAPHIC 58788
4 GRAPHIC b701404-20f_01x4x1.jpg GRAPHIC 18686
5 GRAPHIC b701404-20f_04x19x1.jpg GRAPHIC 75219
6 GRAPHIC b701404-20f_09x43x1.jpg GRAPHIC 36183
7 GRAPHIC b701404-20f_11x53x1.jpg GRAPHIC 61913
8 GRAPHIC b701404-20f_14x67x1.jpg GRAPHIC 396623
9 GRAPHIC b701404-covers_01x1x1.jpg GRAPHIC 955109
10 GRAPHIC b701404-p55x55x1.jpg GRAPHIC 394768
11 GRAPHIC emptybox.gif GRAPHIC 1218
12 GRAPHIC pharmsalesx56x1.jpg GRAPHIC 45599
13 GRAPHIC tickedbox.gif GRAPHIC 1267
14 PDF gsk_report.pdf 20-F 2714721
15 b701404-ex1.txt EX-1 224626
16 b701404ex10-1.htm EX-10 1379
  Complete submission text file 0001021231-03-000405.txt   8981891
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filer) CIK: 0001131399 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 001-15170 | Film No.: 03623118
SIC: 2834 Pharmaceutical Preparations